<DOC>
	<DOCNO>NCT02403219</DOCNO>
	<brief_summary>This prospective , comparative , contralateral eye study . Patients older 18 year treatment topical lubricant least 1 month persist symptom dry eye corneal stain fluorescein include . Patients dry eye attributable abnormality eyelid , nasolacrimal obstruction active corneal infection , well patient severe dry eye exclude study . One eye randomly receive subcutaneous injection botulinum toxin medial part lower eyelid , eye receive similar procedure placebo . The subjective evaluation achieve questionnaire assessing symptom dry eye conjunctivitis , quality vision ocular comfort level eye separately . The objective evaluation include measurement tear film break time , Schirmer 's test modification Oxford grade scheme corneal conjunctival staining .</brief_summary>
	<brief_title>Paralysis Orbicularis Muscle Eye Treatment Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Treatment topical lubricant least 1 month persist symptom dry eye corneal stain fluorescein . Dry eye patient attributable abnormality eyelid ( problem mechanism blinking , poor eyelid position , change position structure eyelash , high surface lesion , etc . ) Nasolacrimal obstruction . Active corneal infection . Patients severe grade 4 dry eye .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Botulinum toxin A</keyword>
	<keyword>Orbicularis muscle eye</keyword>
</DOC>